- Device and diagnostics startups: 6 to watch
- 2013's biggest job-cutters in medical devices and diagnostics (so far)
- Top 10 Biotech CEO Pay Packages of 2012
- The Future of Nanotech Drug Delivery
- 20 Highest-Paid Biopharma CEOs of 2012
- Top 10 Cardio Drugs 2012
- UPDATED: After tough times, hip implant revenue projected to grow again
- The Top 15 Biotech VC firms
- Top 10 pharma companies by employees
- Top 10 Biotech IT Investments in the past year
- 2012's 10 highest-paid Med Tech CEOs
- Fierce's 10 top biotech billionaires
- Drug-Delivery Device Combos to Watch
- Top Pharma Companies by 2012 Revenues
- Med Tech's 2012 R&D big spenders
- Fierce's top 5 feats in life sciences 'gamification'
- Biopharma's Top R&D Spenders - 2012
- Top 5 Vaccine Companies by Revenue - 2012
- Devicemakers plot paths out of CRM funk
- Top 10 Medical Device Moneymakers
THE LIBRARY: WEBINAR
The Basics of Biotech 101, 201 & 301
This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. This series provides an overview of the science and technology used to enable discovery and the processes scientists use to discover new therapeutics. Download now.
Latest Commentary
Analysis: AMA decision on obesity will boost drug R&D in a troubled field
Grow your network with FierceBiotech on LinkedIn
Hunt for 2013 Fierce 15 begins… Release the biotech hounds!
ASCO confab highlights immunotherapies, 'breakthrough' drugs and small victories
FDA oncology chief Pazdur vows to accelerate 'breakthrough' drug R&D
more
EVENTS
- BioClinica is Making DIA Fun! June 23-27 — Boston, MA
- BioBasics: Biotech for the Non-ScientistSeptember 16-17 — Boston, MA
- BioImmersion Three-Day CourseOctober 16-18 — Washington, D.C.
Press Releases
- Antitrust: Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines
- Vertos Medical Raises $23 Million in Series E Financing
- NIH to fund collaborations with industry to identify new uses for existing compounds
- Sarepta Therapeutics Announces Eteplirsen Demonstrates a Continued Benefit on Walking Test Through 84 Weeks in Phase IIb Study in Duchenne Muscular Dystrophy
- AstraZeneca and Bristol-Myers Squibb announce top-line results for SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® (SAXAGLIPTIN)
- More Press Releases
Featured Jobs
-
Director of Biologics
Bristol-Myers Squibb - Syracuse, NY -
Hematology Oncology Consultant (Multiple Myeloma) - Baltimore West Job
Celgene Corporation - Baltimore MD US -
Director, National Accounts Management Job
Celgene Corporation - Chicago IL US -
CLINICAL SCIENCE MANAGER HCV THERAPEUTIC AREA MIDWEST (MI, KY, OH, W VA) - 130000001D
Abbvie - North Chicago IL United States -
SENIOR PROJECT MANAGER - GLOBAL MEDICAL PUBLICATIONS - 130000024H
Abbvie - Chicago IL United States
